These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 11482079)
1. The levels of C3 and C4 components of the complement in the sera of relapsing-remitting multiple sclerosis patients (RR-MS) treated by 2-CDA (cladribine). Bartosik-Psujek H; Stelmasiak Z; Mitosek-Szewczyk K; Belniak-Legieć E; Dobosz B Ann Univ Mariae Curie Sklodowska Med; 2000; 55():231-4. PubMed ID: 11482079 [No Abstract] [Full Text] [Related]
2. Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine. Bartosik-Psujek H; Belniak E; Mitosek-Szewczyk K; Dobosz B; Stelmasiak Z Acta Neurol Scand; 2004 Jun; 109(6):390-2. PubMed ID: 15147461 [TBL] [Abstract][Full Text] [Related]
3. The effect of cladribine on some parameters of blood and cerebrospinal fluid in patients with relapsing-remitting multiple sclerosis (RR-MS). Stelmasiak Z; Bartosik-Psujek H; Belniak-Legieć E; Mitosek-Szewczyk K Ann Univ Mariae Curie Sklodowska Med; 2000; 55():221-5. PubMed ID: 11482077 [No Abstract] [Full Text] [Related]
4. Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: proteomic analysis. Sawai S; Umemura H; Mori M; Satoh M; Hayakawa S; Kodera Y; Tomonaga T; Kuwabara S; Nomura F J Neuroimmunol; 2010 Jan; 218(1-2):112-5. PubMed ID: 19923011 [TBL] [Abstract][Full Text] [Related]
5. Levels of some complement components in azoospermic, oligospermic and normospermic Nigerian men. Oyeyinka GO; Bello CS; Elegba OY; Nsofor BI J Reprod Med; 1987 Oct; 32(10):774-6. PubMed ID: 3500310 [TBL] [Abstract][Full Text] [Related]
6. [Levels of complement components in sera and pleural fluid in patients with various types of pleural pathology]. Cicioğlu R; Enacar N; Karabiyikoğlu G; Numanoğlu N Mikrobiyol Bul; 1987 Jul; 21(3):185-93. PubMed ID: 3141750 [TBL] [Abstract][Full Text] [Related]
7. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400 [TBL] [Abstract][Full Text] [Related]
8. Cladribine: mode of action and implications for treatment of multiple sclerosis. Leist TP; Weissert R Clin Neuropharmacol; 2011; 34(1):28-35. PubMed ID: 21242742 [TBL] [Abstract][Full Text] [Related]
9. [The effect of cladribine treatment on beta-2 microglobin in the cerebrospinal fluid and serum of patients with multiple sclerosis]. Niezgoda A; Losy J Neurol Neurochir Pol; 2000; 34(2):281-7. PubMed ID: 10962721 [TBL] [Abstract][Full Text] [Related]
10. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis. Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245 [TBL] [Abstract][Full Text] [Related]
12. [Determination of components C3-C4 of complement in patients after autotransfusion]. Ramaioli F; Merati P; Moratti R; Pagani I; Marra M; De Amici D; Della Marta ME Minerva Anestesiol; 1990 Oct; 56(10):1109-11. PubMed ID: 2290516 [No Abstract] [Full Text] [Related]
13. [Immunologic follow-up of HIV-positive patients. C3, C4 complement components during HIV infection]. Skokanová V; Kamínková J; Vacek Z; Stanková M Cas Lek Cesk; 1993 Sep; 132(17):526-8. PubMed ID: 8402822 [TBL] [Abstract][Full Text] [Related]
14. [Values of C3 and C4 components of the complement system during the administration of amino acids in dialysed patients]. Jeren B; Prejac M; Vitunjski B Acta Med Iugosl; 1978; 32(5):407-18. PubMed ID: 742404 [No Abstract] [Full Text] [Related]
15. Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis. Schwarz M; Spector L; Gortler M; Weisshaus O; Glass-Marmor L; Karni A; Dotan N; Miller A J Neurol Sci; 2006 May; 244(1-2):59-68. PubMed ID: 16480743 [TBL] [Abstract][Full Text] [Related]
16. Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosis. Sipe JC Expert Rev Neurother; 2010 Mar; 10(3):365-75. PubMed ID: 20187859 [TBL] [Abstract][Full Text] [Related]
17. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation. Dernellis J; Panaretou M Am J Cardiol; 2006 Jan; 97(2):245-8. PubMed ID: 16442371 [TBL] [Abstract][Full Text] [Related]